Single ascending dose
Showing 1 - 25 of >10,000
Metastatic Breast Cancer Trial in Amman (Fulvestrant injection)
Completed
- Metastatic Breast Cancer
- Fulvestrant injection
-
Amman, JordanTriumpharma Cro
Oct 3, 2023
Healthy Volunteers Trial in Copenhagen (AP31969, Placebo)
Not yet recruiting
- Healthy Volunteers
- AP31969
- Placebo
-
Copenhagen, DenmarkAcesion Pharma
Sep 27, 2023
Alopecia Areata Trial in Randwick (OR-101 (Single ascending dose), OR-101 (Food effect), OR-101 (Multiple ascending dose))
Not yet recruiting
- Alopecia Areata
- OR-101 (Single ascending dose)
- +3 more
-
Randwick, New South Wales, AustraliaSCIENTIA Clinical Research Ltd
Sep 13, 2023
Non-alcoholic Steatohepatitis Trial (AZD9550, Placebo)
Not yet recruiting
- Non-alcoholic Steatohepatitis
- AZD9550
- Placebo
- (no location specified)
Apr 27, 2023
Ulcerative Colitis Trial in Seoul (INV-101)
Completed
- Ulcerative Colitis
-
Seoul, Korea, Republic ofInnovo Therapeutics, Inc.
Apr 25, 2023
Healthy Volunteers Trial in Secaucus (NRS-033, Placebo)
Not yet recruiting
- Healthy Volunteers
- NRS-033
- Placebo
-
Secaucus, New JerseyFrontage Clinical Research Center
Feb 10, 2023
Healthy Adult Subjects Trial in Seoul (ID110521156, Placebo of ID110521156)
Not yet recruiting
- Healthy Adult Subjects
- ID110521156
- Placebo of ID110521156
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 26, 2023
Myocardial Infarction Trial in Adelaide (NP-011 (Single Ascending Dose Phase), NP-011 (Multiple Ascending Dose Phase), NP-011
Recruiting
- Myocardial Infarction
- NP-011 (Single Ascending Dose Phase)
- +2 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Sep 26, 2022
Hypertension Trial in Beijing (SPH3127)
Completed
- Hypertension
-
Beijing, Beijing, ChinaThe capital medical university affiliated Beijing anzhen hospita
Oct 26, 2022
Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending
Not yet recruiting
- Bladder Cancer
- APL-1202 and APL-1501 (Single ascending dose)
- APL-1202 and APL-1501 (Multiple Ascending dose)
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Sep 11, 2023
Acute Ischemic Stroke Trial in Baltimore (NTS-104 TRIS, Placebo)
Not yet recruiting
- Acute Ischemic Stroke
- NTS-104 TRIS
- Placebo
-
Baltimore, MarylandParexel International EPCU Baltimore 7th floor
Sep 16, 2022
Healthy Subjects Trial in Melbourne (ISM5411, Placebo)
Not yet recruiting
- Healthy Subjects
- ISM5411
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Network
Aug 22, 2023
Healthy Volunteers Trial in Herston (MDK-703 or Placebo)
Recruiting
- Healthy Volunteers
- MDK-703 or Placebo
-
Herston, Queensland, AustraliaMedikine Clinical Site
Jul 22, 2022
Healthy Trial in Toronto (ABX1100 injection for IV infusion, Placebo injection for IV infusion)
Recruiting
- Healthy
- ABX1100 injection for IV infusion
- Placebo injection for IV infusion
-
Toronto, CanadaStudy Site
Oct 25, 2023
Healthy Trial in Beijing (MT200605 for Injection, MT200605 Placebo)
Enrolling by invitation
- Healthy
- MT200605 for Injection
- MT200605 Placebo
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Jul 13, 2023
To Reduce the LDL-C Level in Hypercholesteremia Patients Trial (RN0191)
Not yet recruiting
- To Reduce the LDL-C Level in Hypercholesteremia Patients
- (no location specified)
Nov 13, 2023
Healthy, Postbariatric Hypoglycemia Trial (MBX 1416 (Part A), MBX 1416 (Part B), Placebo)
Not yet recruiting
- Healthy
- Postbariatric Hypoglycemia
- MBX 1416 (Part A)
- +2 more
- (no location specified)
Sep 11, 2023